An open-label, multicentre clinical trial to determine the levodopa dose-sparing capacity of pramipexole in patients with idiopathic Parkinson's disease. [electronic resource]
Producer: 20010301Description: 1307-23 p. digitalISSN:- 0300-9564
- Aged
- Antiparkinson Agents -- administration & dosage
- Benzothiazoles
- Dopamine Agonists -- adverse effects
- Dose-Response Relationship, Drug
- Female
- Humans
- Levodopa -- administration & dosage
- Male
- Middle Aged
- Parkinson Disease -- drug therapy
- Pramipexole
- Prospective Studies
- Thiazoles -- adverse effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.